Paninvest Tbk PT
Paninvest Tbk PT operates in the life and health insurance sector, generating revenue primarily through insurance premiums and investment income from its asset base.
Business. Paninvest Tbk PT (PNIN.JK) is an Indonesian life and health insurance company headquartered in Jakarta. The firm operates within the financials sector, specifically focusing on the life and health insurance industry. It is primarily listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Paninvest Tbk PT (PNIN.JK) is an Indonesian life and health insurance company headquartered in Jakarta. The firm operates within the financials sector, specifically focusing on the life and health insurance industry. It is primarily listed on the Indonesia Stock Exchange (IDX). Specific details regarding operating segments or geographic revenue breakdowns are not available.
Paninvest Tbk PT maintains a capital structure with a debt-to-equity ratio of 6.94, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with free cash flow of 348.56 billion IDR and cash and equivalents of 4.28 billion IDR, but this is offset by long-term debt of 155.33 trillion IDR. The return on equity of 4.19% is below the typical industry benchmark for life and health insurers, suggesting suboptimal capital efficiency.
Profitability metrics show a return on assets of 0.37%, which is well below the median for the industry, indicating that the company is not effectively leveraging its asset base to generate returns. Operating income of 24.7 billion IDR and net income of 9.37 billion IDR suggest a relatively narrow margin, which may limit the company's ability to withstand economic downturns or competitive pressures.
The company's revenue is not segmented by product or geography in the available data, but the concentration of revenue in a single business line (life and health insurance) may expose it to sector-specific risks. There is no indication of geographic diversification in the provided data, which could increase vulnerability to regional economic or regulatory shifts.
Looking ahead, the company's growth trajectory is not explicitly outlined in the data, but the operating income and net income figures suggest a stable, albeit modest, performance. The capital expenditure of -432.08 billion IDR indicates a reduction in capital spending, which may reflect a strategic shift or a response to financial constraints.
Risk factors include a medium liquidity risk due to the company's high debt load and relatively low cash reserves. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet long-term obligations without further financing.
Recent events, including analyst estimates of last actual EPS at 78.00 IDR and revenue at 1.24 trillion IDR, suggest a stable earnings performance in the most recent reporting period. No recent filings or transcripts are provided to indicate strategic changes or operational developments.
- Paninvest Tbk PT has a high debt-to-equity ratio of 6.94, indicating a heavy reliance on debt financing.
- The company's return on equity of 4.19% is below the typical industry benchmark, suggesting suboptimal capital efficiency.
- The company's liquidity position is medium, with free cash flow of 348.56 billion IDR but a long-term debt of 155.33 trillion IDR.
- The company's return on assets of 0.37% is well below the median for the industry, indicating poor asset utilization.
- The company's revenue is not segmented by product or geography, which may increase vulnerability to sector-specific risks.
- The company's capital expenditure is negative, indicating a reduction in capital spending.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Paninvest Tbk PT Market data — financials · 2026-05-29
- Paninvest Tbk PT Market data — analyst estimates · 2026-05-29